Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

August 01, 2011; Volume 338,Issue 2

Highlighted Papers

  • You have access
    Effectiveness of Therapeutic Antibodies against Bioterrorism and Biological Warfare
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 411;
  • You have access
    Therapeutic Potential of siRNA Targeting RelA in Atopic Dermatitis
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 411;
  • You have access
    Functional Cross-Talk between Purinergic and Cysteinyl-Leukotriene Ligands
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 411;
  • You have access
    A New Profile Anticoagulant Combining Factor Xa and αIIbβ3 Inhibition
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 411;

Behavioral Pharmacology

  • You have access
    The Role of 5-Hydroxytryptamine 7 Receptors in the Phencyclidine-Induced Novel Object Recognition Deficit in Rats
    M. Horiguchi, M. Huang and H. Y. Meltzer
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 605-614; DOI: https://doi.org/10.1124/jpet.111.180638
  • You have access
    Anxiolytic-Like Activity of Pregabalin in the Vogel Conflict Test in α2δ-1 (R217A) and α2δ-2 (R279A) Mouse Mutants
    Susan M. Lotarski, Sean Donevan, Ayman El-Kattan, Sarah Osgood, Julie Poe, Charles P. Taylor and James Offord
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 615-621; DOI: https://doi.org/10.1124/jpet.111.180976
  • You have access
    Effects of Repeated Treatment with Phosphodiesterase-4 Inhibitors on cAMP Signaling, Hippocampal Cell Proliferation, and Behavior in the Forced-Swim Test
    Lan Xiao, James P. O'Callaghan and James M. O'Donnell
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 641-647; DOI: https://doi.org/10.1124/jpet.111.179358

Cardiovascular

  • You have access
    The Antithrombotic Activity of EP224283, a Neutralizable Dual Factor Xa Inhibitor/Glycoprotein IIbIIIa Antagonist, Exceeds That of the Coadministered Parent Compounds
    Béatrice Hechler, Monique Freund, Ghina Alame, Cécile Leguay, Sébastien Gaertner, Jean-Pierre Cazenave, Maurice Petitou and Christian Gachet
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 412-420; DOI: https://doi.org/10.1124/jpet.111.181321
  • You have access
    Combinatorial Effect of Probucol and Cilostazol in Focal Ischemic Mice with Hypercholesterolemia
    Ji Hyun Kim, Sun Haeng Park, Sun Sik Bae, Ki Whan Hong, Yong Deok Kim, Kyung Pil Park, Byung Tae Choi and Hwa Kyoung Shin
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 451-457; DOI: https://doi.org/10.1124/jpet.111.181180
  • You have access
    Hydrogen Sulfide in the Rostral Ventrolateral Medulla Inhibits Sympathetic Vasomotor Tone through ATP-Sensitive K+ Channels
    Qi Guo, Sheng Jin, Xiu-Li Wang, Ru Wang, Lin Xiao, Rui-rong He and Yu-ming Wu
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 458-465; DOI: https://doi.org/10.1124/jpet.111.180711
  • You have access
    Compound C Inhibits Vascular Smooth Muscle Cell Proliferation and Migration in an AMP-Activated Protein Kinase-Independent Fashion
    Kelly J. Peyton, Yajie Yu, Benjamin Yates, Ahmad R. Shebib, Xiao-ming Liu, Hong Wang and William Durante
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 476-484; DOI: https://doi.org/10.1124/jpet.111.181784
  • You have access
    Astragaloside IV Stimulates Angiogenesis and Increases Hypoxia-Inducible Factor-1α Accumulation via Phosphatidylinositol 3-Kinase/Akt Pathway
    Ling Zhang, Qian Liu, Lin Lu, Xiaoping Zhao, Xiumei Gao and Yi Wang
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 485-491; DOI: https://doi.org/10.1124/jpet.111.180992
  • You have access
    NADPH Oxidase Pathway Is Involved in Aortic Contraction Induced by A3 Adenosine Receptor in Mice
    Mohammed S. El-Awady, Habib R. Ansari, Daniel Fil, Stephen L. Tilley and S. Jamal Mustafa
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 711-717; DOI: https://doi.org/10.1124/jpet.111.180828

Cellular and Molecular

  • You have access
    The Cytochrome P450 4A/F-20-Hydroxyeicosatetraenoic Acid System: A Regulator of Endothelial Precursor Cells Derived from Human Umbilical Cord Blood
    Austin M. Guo, Branislava Janic, Ju Sheng, John R. Falck, Richard J. Roman, Paul A. Edwards, Ali S. Arbab and A. Guillermo Scicli
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 421-429; DOI: https://doi.org/10.1124/jpet.111.179036
  • You have access
    Salt Bridges Overlapping the Gonadotropin-Releasing Hormone Receptor Agonist Binding Site Reveal a Coincidence Detector for G Protein-Coupled Receptor Activation
    Jo Ann Janovick, Irina D. Pogozheva, Henry I. Mosberg and P. Michael Conn
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 430-442; DOI: https://doi.org/10.1124/jpet.111.180869
  • You have access
    Agonist-Induced Desensitization/Resensitization of Human G Protein-Coupled Receptor 17: A Functional Cross-Talk between Purinergic and Cysteinyl-Leukotriene Ligands
    S. Daniele, M. L. Trincavelli, P. Gabelloni, D. Lecca, P. Rosa, M. P. Abbracchio and C. Martini
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 559-567; DOI: https://doi.org/10.1124/jpet.110.178715
  • You have access
    Analysis of Functional Responses at G Protein-Coupled Receptors: Estimation of Relative Affinity Constants for the Inactive Receptor State
    Frederick J. Ehlert, Michael T. Griffin and Hinako Suga
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 658-670; DOI: https://doi.org/10.1124/jpet.111.179291
  • You have access
    Analysis of Agonism and Inverse Agonism in Functional Assays with Constitutive Activity: Estimation of Orthosteric Ligand Affinity Constants for Active and Inactive Receptor States
    Frederick J. Ehlert, Hinako Suga and Michael T. Griffin
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 671-686; DOI: https://doi.org/10.1124/jpet.111.179309
  • You have access
    NaVβ Subunits Modulate the Inhibition of NaV1.8 by the Analgesic Gating Modifier μO-Conotoxin MrVIB
    Michael J. Wilson, Min-Min Zhang, Layla Azam, Baldomero M. Olivera, Grzegorz Bulaj and Doju Yoshikami
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 687-693; DOI: https://doi.org/10.1124/jpet.110.178343
  • You have access
    Involvement of Matrix Metalloproteinase-Mediated Proteolysis of Neural Cell Adhesion Molecule in the Development of Cerebral Ischemic Neuronal Damage
    Kanako Shichi, Wakako Fujita-Hamabe, Shinichi Harada, Hiroyuki Mizoguchi, Kiyofumi Yamada, Toshitaka Nabeshima and Shogo Tokuyama
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 701-710; DOI: https://doi.org/10.1124/jpet.110.178079

Chemotherapy, Antibiotics, and Gene Therapy

  • You have access
    Therapeutic Effects on Atopic Dermatitis by Anti-RelA Short Interfering RNA Combined with Functional Peptides Tat and AT1002
    Tamae Uchida, Takanori Kanazawa, Misako Kawai, Yuuki Takashima and Hiroaki Okada
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 443-450; DOI: https://doi.org/10.1124/jpet.111.180042
  • You have access
    A Calcineurin-Independent Mechanism of Angiogenesis Inhibition by a Nonimmunosuppressive Cyclosporin A Analog
    Benjamin A. Nacev, Woon-Kai Low, Zhennian Huang, Tina T. Su, Zhuang Su, Hisham Alkuraya, Dan Kasuga, Woong Sun, Mario Träger, Manfred Braun, Gunter Fischer, Kang Zhang and Jun O. Liu
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 466-475; DOI: https://doi.org/10.1124/jpet.111.180851
  • You have access
    Oxaliplatin Transport Mediated by Organic Cation/Carnitine Transporters OCTN1 and OCTN2 in Overexpressing Human Embryonic Kidney 293 Cells and Rat Dorsal Root Ganglion Neurons
    Nancy N. Jong, Takeo Nakanishi, Johnson J. Liu, Ikumi Tamai and Mark J. McKeage
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 537-547; DOI: https://doi.org/10.1124/jpet.111.181297

Drug Discovery and Translational Medicine

  • You have access
    A Rate-Limiting Role for Dickkopf-1 in Bone Formation and the Remediation of Bone Loss in Mouse and Primate Models of Postmenopausal Osteoporosis by an Experimental Therapeutic Antibody
    Helmut Glantschnig, Kevin Scott, Richard Hampton, Nan Wei, Paul McCracken, Pascale Nantermet, Jing Z. Zhao, Salvatore Vitelli, Lingyi Huang, Peter Haytko, Ping Lu, John E. Fisher, Punam Sandhu, Jacquelynn Cook, Donald Williams, William Strohl, Osvaldo Flores, Donald Kimmel, Fubao Wang and Zhiqiang An
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 568-578; DOI: https://doi.org/10.1124/jpet.111.181404

Endocrine and Diabetes

  • You have access
    Decreased Cytochrome c Oxidase IV Expression Reduces Steroidogenesis
    Kevin J. Pawlak, Manoj Prasad, Kevin A. McKenzie, John P. Wiebe, C. Gary Gairola, Randy M. Whittal and Himangshu S. Bose
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 598-604; DOI: https://doi.org/10.1124/jpet.111.182634

Gastrointestinal, Hepatic, Pulmonary, and Renal

  • You have access
    Intermediate-Conductance Ca2+-Activated K+ Channel, KCa3.1, as a Novel Therapeutic Target for Benign Prostatic Hyperplasia
    Susumu Ohya, Satomi Niwa, Yoshiyuki Kojima, Shoichi Sasaki, Motomu Sakuragi, Kenjiro Kohri and Yuji Imaizumi
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 528-536; DOI: https://doi.org/10.1124/jpet.111.182782

Inflammation, Immunopharmacology, and Asthma

  • You have access
    Paw Inflammation Model in Dogs for Preclinical Pharmacokinetic/Pharmacodynamic Investigations of Nonsteroidal Anti-Inflammatory Drugs
    E. C. Jeunesse, I. A. Bargues, C. E. Toutain, M. Z. Lacroix, I. M. Letellier, J. M. Giraudel and P. L. Toutain
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 548-558; DOI: https://doi.org/10.1124/jpet.110.178350
  • You have access
    α1-Adrenergic Receptors Positively Regulate Toll-Like Receptor Cytokine Production from Human Monocytes and Macrophages
    Laurel A. Grisanti, Andrew P. Woster, Julie Dahlman, Edward R. Sauter, Colin K. Combs and James E. Porter
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 648-657; DOI: https://doi.org/10.1124/jpet.110.178012

Metabolism, Transport, and Pharmacogenomics

  • You have access
    Physiological and Molecular Characterization of Aristolochic Acid Transport by the Kidney
    Kathleen G. Dickman, Douglas H. Sweet, Radha Bonala, Tapan Ray and Amy Wu
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 588-597; DOI: https://doi.org/10.1124/jpet.111.180984

Neuropharmacology

  • You have access
    Pentazocine-Induced Antinociception Is Mediated Mainly by μ-Opioid Receptors and Compromised by κ-Opioid Receptors in Mice
    Haihua Shu, Masakazu Hayashida, Hideko Arita, Wenqi Huang, Hui Zhang, Ke An, Guiyun Wu and Kazuo Hanaoka
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 579-587; DOI: https://doi.org/10.1124/jpet.111.179879
  • You have access
    Pharmacological Characterization of LY593093, an M1 Muscarinic Acetylcholine Receptor-Selective Partial Orthosteric Agonist
    Marla L. Watt, Douglas A. Schober, Stephen Hitchcock, Bin Liu, Amy K. Chesterfield, David McKinzie and Christian C. Felder
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 622-632; DOI: https://doi.org/10.1124/jpet.111.182063
  • You have access
    A Novel Knock-In Mouse Reveals Mechanistically Distinct Forms of Morphine Tolerance
    Johan Enquist, Joseph A. Kim, Selena Bartlett, Madeline Ferwerda and Jennifer L. Whistler
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 633-640; DOI: https://doi.org/10.1124/jpet.111.179754
  • You have access
    The Akt-Nitric Oxide-cGMP Pathway Contributes to Nerve Growth Factor-Mediated Neurite Outgrowth in Apolipoprotein E Knockout Mice
    Narumi Hashikawa-Hobara, Naoya Hashikawa, Chikao Yutani, Yoshito Zamami, Xin Jin, Shingo Takatori, Mitsunobu Mio and Hiromu Kawasaki
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 694-700; DOI: https://doi.org/10.1124/jpet.111.181487
  • You have access
    The Affinity of D2-Like Dopamine Receptor Antagonists Determines the Time to Maximal Effect on Cocaine Self-Administration
    Andrew B. Norman, Michael R. Tabet, Mantana K. Norman, Brittney K. Fey, Vladimir L. Tsibulsky and Ronald W. Millard
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 724-728; DOI: https://doi.org/10.1124/jpet.111.183244

Toxicology

  • You have access
    The Role of Hypoxia-Inducible Factor-1α in Acetaminophen Hepatotoxicity
    Erica M. Sparkenbaugh, Yogesh Saini, Krista K. Greenwood, John J. LaPres, James P. Luyendyk, Bryan L. Copple, Jane F. Maddox, Patricia E. Ganey and Robert A. Roth
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 492-502; DOI: https://doi.org/10.1124/jpet.111.180521
  • You have access
    Identification of the Factors That Govern the Ability of Therapeutic Antibodies to Provide Postchallenge Protection Against Botulinum Toxin: A Model for Assessing Postchallenge Efficacy of Medical Countermeasures against Agents of Bioterrorism and Biological Warfare
    Fetweh H. Al-Saleem, Zidoon Nasser, Rebecca M. Olson, Linsen Cao and Lance L. Simpson
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 503-517; DOI: https://doi.org/10.1124/jpet.111.180653
  • You have access
    Exposure to an Environmental Neurotoxicant Hastens the Onset of Amyotrophic Lateral Sclerosis-Like Phenotype in Human Cu2+/Zn2+ Superoxide Dismutase 1 G93A Mice: Glutamate-Mediated Excitotoxicity
    Frank O. Johnson, Yukun Yuan, Ravindra K. Hajela, Alisha Chitrakar, Dawn M. Parsell and William D. Atchison
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 518-527; DOI: https://doi.org/10.1124/jpet.110.174466
  • You have access
    Influence of Dosing Time on the Efficacy and Safety of Finasteride in Rats
    Masafumi Kumazaki, Hitoshi Ando, Kentarou Ushijima, Tomohiro Maekawa, Yuya Motosugi, Makoto Takada, Masato Tateishi and Akio Fujimura
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 718-723; DOI: https://doi.org/10.1124/jpet.111.182865

Erratum

  • You have access
    Correction to “The Microtubule-Targeting Agents, PBOX-6 [Pyrrolobenzoxazepine 7-[(dimethylcarbamoyl)oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine] and Paclitaxel, Induce Nucleocytoplasmic Redistribution of the Peptidyl-Prolyl Isomerases, Cyclophilin A and Pin1, in Malignant Hematopoietic Cells”
    Journal of Pharmacology and Experimental Therapeutics August 2011, 338 (2) 729;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 338 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 338, Issue 2
1 Aug 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Highlighted Papers
  • Behavioral Pharmacology
  • Cardiovascular
  • Cellular and Molecular
  • Chemotherapy, Antibiotics, and Gene Therapy
  • Drug Discovery and Translational Medicine
  • Endocrine and Diabetes
  • Gastrointestinal, Hepatic, Pulmonary, and Renal
  • Inflammation, Immunopharmacology, and Asthma
  • Metabolism, Transport, and Pharmacogenomics
  • Neuropharmacology
  • Toxicology
  • Erratum
  • Most Read
Loading
  • Potential Clinical Uses of CBG
  • Ocular Drug Delivery: Past, Present, and Future
  • Rho GTPase–Pathway Inhibitor Reduces Markers of Fibrosis
  • Nose-to-Brain Delivery
  • SEP-363856, a Novel, Non-D2 Psychotropic Agent
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics